查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1939340

2026年全球生物晶片市場報告

Biochips Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，生物晶片市場發展迅速，預計將從2025年的146.1億美元成長到2026年的169.7億美元，複合年成長率達16.1%。過去幾年的成長可歸因於基因組學和蛋白​​質組學研究的進步、製藥和生物技術領域研發項目的擴展、DNA微陣列在基因篩檢中的應用、生物晶片在分子診斷中日益廣泛的應用，以及基於微陣列和微流體技術的分析平台的發展。

預計未來幾年生物晶片市場將快速成長，到2030年市場規模將達到290.3億美元，複合年成長率（CAGR）為14.4%。預測期內的成長要素包括：精準醫療和個人化治療需求的不斷成長；實驗室晶片技術在臨床檢測中的應用日益廣泛；生物標記發現和轉化研究領域的投資不斷增加；生物晶片在農業和生命科學領域的應用範圍不斷擴大；以及基於先進生物晶片的診斷工具的商業化進程不斷加快。預測期內的關鍵趨勢包括：生物晶片在基因序列測定和疾病診斷領域的應用日益廣泛；蛋白質和細胞陣列在先進生物分子研究中的應用日益增多；就地檢驗對實驗室晶片平台的需求不斷成長；生物晶片在藥物發現和開發領域的應用不斷擴大；以及對小型化和高通量生物數據分析的關注。

由於個人化醫療的日益普及，生物晶片市場預計將會成長。個人化醫療是一種基於個別特徵（例如基因資訊和生活方式習慣）最佳化治療方法的醫療模式，旨在最大限度地提高療效並最大限度地減少副作用。這一趨勢的促進因素包括個人化醫療在提供更有效治療方面的潛力、基因組學的進步、疾病複雜性的增加以及監管支持。生物晶片在個人化醫療中發揮關鍵作用，它能夠根據個體的基因譜制定精準的個人化治療方案。例如，截至2024年2月，美國食品藥物管理局（FDA）在2023年核准了16種針對罕見疾病的新型個人化療法，顯示個人化醫療的普及正在加速，並對生物晶片市場產生影響。

生物晶片市場的主要企業正致力於開發尖端技術，例如「晶片器官」平台，這將徹底改變藥物發現和開發流程。 「晶片器官」平台是一種先進的微流體裝置，旨在以微小尺度複製人體器官的生理特性和功能。例如，2024年4月，波士頓微製造公司（BMF）成立了BMF生物技術公司，該公司專注於大規模體外組織培養的生物晶片/晶片器官平台。這項技術進步有望透過提供體外測試和研究平台，加速藥品和化妝品的開發。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球生物晶片市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 人工智慧（AI）和自主人工智慧
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 生物晶片在基因定序和疾病診斷的應用日益廣泛
    • 蛋白質和細胞陣列在先進生物分子研究中的廣泛應用
    • 即時檢測領域對晶片實驗室平台的需求日益成長
    • 拓展生物晶片在藥物發現與開發的應用範圍
    • 專注於小型化和高通量生物數據分析

第5章 終端用戶產業市場分析

  • 生物技術和製藥公司
  • 學術研究機構
  • 醫院和診斷中心
  • 合約研究機構
  • 公共衛生與基因組學研究所

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球生物晶片市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球生物晶片市場規模、比較及成長率分析
  • 全球生物晶片市場表現：規模與成長，2020-2025年
  • 全球生物晶片市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 去氧核糖核酸（DNA）晶片、蛋白質晶片、晶片實驗室、組織晶片、細胞晶片
  • 透過技術
  • 微陣列、微流體技術
  • 透過使用
  • 藥物發現與開發、農業、基因體學、疾病診斷、蛋白質體學及其他應用領域
  • 最終用戶
  • 生物技術和製藥公司、學術研究機構、醫院和診斷中心以及其他最終用戶
  • 按類型細分：去氧核糖核酸(DNA) 晶片
  • 基因表現晶片、SNP（單核苷酸多態性）晶片、DNA微陣列
  • 按類型細分：蛋白質晶片
  • 抗體晶片、蛋白質微陣列、胜肽晶片
  • 按類型細分：晶片實驗室
  • 微流體控裝置、生物感測器
  • 按類型細分：組織晶片
  • 腫瘤組織晶片，正常組織晶片
  • 按類型細分：細胞陣列
  • 基於細胞的生物晶片、細胞訊號陣列

第10章 區域與國家分析

  • 全球生物晶片市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球生物晶片市場：依國家、性能及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 生物晶片市場：競爭格局及市場佔有率（2024年）
  • 生物晶片市場：公司估值矩陣
  • 生物晶片市場：公司概況
    • Thermo Fisher Scientific Inc.
    • Roche Diagnostics International Ltd
    • Agilent Technologies Inc.
    • PerkinElmer Inc.
    • Illumina Inc.

第37章：其他領先和創新企業

  • Bio-Rad Laboratories Inc., QIAGEN NV, Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies BV, Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., NanoCellect Biomedical Inc., Dolomite Microfluidics

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年生物晶片市場：提供新機會的國家
  • 2030年生物晶片市場：蘊藏新機會的細分市場
  • 2030年生物晶片市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MBIOC07_G26Q1

Biochips are compact devices containing an assortment of biological substances such as DNA, proteins, or cells, affixed onto a solid surface. They merge biological components with electronic systems for studying and manipulating biological data, finding extensive use in medical diagnostics, genetic sequencing, and other biotechnological domains.

The primary types of biochips include DNA chips (or DNA microarrays), protein chips, lab-on-chip systems, tissue arrays, and cell arrays. DNA chips allow the simultaneous analysis of numerous genes' expressions, leveraging technologies such as microarrays and microfluidics. These biochips find applications in drug discovery, agriculture, genomics, disease diagnostics, proteomics, and are utilized by diverse end users such as biotech firms, pharmaceutical companies, academic institutions, hospitals, and diagnostic centers.

Tariffs are affecting the biochips market by increasing the cost of semiconductor substrates, microfluidic components, biosensor electronics, and assay reagents that rely on global manufacturing and cross-border supply chains, leading to higher production and procurement costs. The impact is more pronounced across dna chips, protein chips, and lab-on-chip platforms manufactured in Asia-Pacific and European hubs where imports of specialty materials and precision components are tariff sensitive. Biotechnology and pharmaceutical companies, academic and research institutes, and hospital diagnostic centers are experiencing extended purchasing cycles and pricing pressures due to tariff-driven cost pass-throughs. However, tariffs are also encouraging localized fabrication, regional component sourcing, and domestic biochip assembly initiatives that may strengthen supply resilience and stimulate long-term innovation investment.

The biochips market research report is one of a series of new reports from The Business Research Company that provides biochips market statistics, including biochips industry global market size, regional shares, competitors with a biochips market share, detailed biochips market segments, market trends and opportunities, and any further data you may need to thrive in the biochips industry. This biochips market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biochips market size has grown rapidly in recent years. It will grow from $14.61 billion in 2025 to $16.97 billion in 2026 at a compound annual growth rate (CAGR) of 16.1%. The growth in the historic period can be attributed to growth in genomics and proteomics research, expansion of pharmaceutical and biotech r&d programs, adoption of dna microarrays in genetic screening, increasing use of biochips in molecular diagnostics, development of microarray and microfluidic-based analytical platforms.

The biochips market size is expected to see rapid growth in the next few years. It will grow to $29.03 billion in 2030 at a compound annual growth rate (CAGR) of 14.4%. The growth in the forecast period can be attributed to rising demand for precision medicine and personalized therapies, growing utilization of lab-on-chip technologies in clinical testing, higher investment in biomarker discovery and translational research, expanding applications of biochips in agriculture and life sciences, increasing commercialization of advanced biochip-based diagnostic tools. Major trends in the forecast period include growing adoption of biochips in genetic sequencing and disease diagnostics, increasing use of protein and cell arrays for advanced biomolecular research, rising demand for lab-on-chip platforms in point-of-care testing, expansion of biochip applications in drug discovery and development, focus on miniaturization and high-throughput biological data analysis.

The biochips market is poised for growth due to the increasing adoption of personalized medicines. Personalized medicine involves tailoring medical treatments based on individual characteristics such as genetics or lifestyle, aiming to optimize effectiveness and minimize adverse effects. This trend is fueled by the potential of personalized medicine to offer more effective treatments, advancements in genomics, the rising complexity of diseases, and regulatory backing. Biochips play a crucial role in personalized medicine by enabling precise and individualized treatment plans based on a person's genetic profile. For instance, in February 2024, the FDA approved 16 novel personalized therapies for rare diseases in 2023, highlighting the momentum in personalized medicine adoption and its impact on the biochips market.

Leading companies in the biochips market are focusing on developing cutting-edge technologies such as organ-on-a-chip platforms to transform drug discovery and development processes. Organ-on-a-chip platforms are sophisticated microfluidic devices designed to mimic the physiological characteristics and functions of human organs on a smaller scale. For example, in April 2024, Boston Micro Fabrication (BMF) launched BMF Biotechnology Inc., specializing in biochips or organ-on-a-chip platforms for cultivating large-scale tissues in vitro. This advancement accelerates drug and cosmetic development by providing a testing and research platform outside the human body.

In June 2023, Randox Laboratories acquired Cellix Limited to bolster its expertise in benchtop flow cytometry, aligning with its commitment to personalized medicine and improved preventive healthcare. This acquisition expands Randox's portfolio and makes flow cytometry technology more accessible to a wider range of researchers and healthcare professionals. Cellix Limited, based in Ireland, specializes in creating biochips for various applications in the life sciences.

Major companies operating in the biochips market are Thermo Fisher Scientific Inc., Roche Diagnostics International Ltd, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., NanoCellect Biomedical Inc., Dolomite Microfluidics, Biocartis NV

North America was the largest region in the biochips market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biochips market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biochips market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The biochips market consists of sales of lab-on-a-chip (LOC) devices, cellular microarrays, and protein microarrays. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biochips Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses biochips market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biochips ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biochips market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Deoxyribonucleic Acid (DNA) Chips; Protein Chips; Lab-On-Chip; Tissue Arrays; Cell Arrays
  • 2) By Technology: Microarrays; Microfluidics
  • 3) By Application: Drug Discovery And Development; Agriculture; Genomics; Disease Diagnostics; Proteomics; Other Applications
  • 4) By End-User: Biotechnology And Pharmaceutical Companies; Academic And Research Institutes; Hospitals And Diagnostic Centers; Other End-Users
  • Subsegments:
  • 1) By Deoxyribonucleic Acid (Dna) Chips: Gene Expression Chips; Snp (Single Nucleotide Polymorphism) Chips; Dna Microarrays
  • 2) By Protein Chips: Antibody Arrays; Protein Microarrays; Peptide Arrays
  • 3) By Lab-On-Chip: Microfluidic Devices; Biosensors
  • 4) By Tissue Arrays: Tumor Tissue Arrays; Normal Tissue Arrays
  • 5) By Cell Arrays: Cell-Based Biochips; Cell Signaling Arrays
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Roche Diagnostics International Ltd; Agilent Technologies Inc.; PerkinElmer Inc.; Illumina Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Tecan Group Ltd.; Cepheid Inc.; Randox Laboratories Ltd.; Takara Bio Inc.; Luminex Corporation; Fluidigm Corporation; Micronit Microtechnologies B.V.; Sphere Fluidics Limited; Sengenics; Arrayit Corporation; CustomArray Inc.; NanoCellect Biomedical Inc.; Dolomite Microfluidics; Biocartis NV
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Biochips Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Biochips Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Biochips Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Biochips Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Artificial Intelligence & Autonomous Intelligence
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Growing Adoption Of Biochips In Genetic Sequencing And Disease Diagnostics
    • 4.2.2 Increasing Use Of Protein And Cell Arrays For Advanced Biomolecular Research
    • 4.2.3 Rising Demand For Lab-On-Chip Platforms In Point-Of-Care Testing
    • 4.2.4 Expansion Of Biochip Applications In Drug Discovery And Development
    • 4.2.5 Focus On Miniaturization And High-Throughput Biological Data Analysis

5. Biochips Market Analysis Of End Use Industries

  • 5.1 Biotechnology And Pharmaceutical Companies
  • 5.2 Academic And Research Institutes
  • 5.3 Hospitals And Diagnostic Centers
  • 5.4 Contract Research Organizations
  • 5.5 Public Health And Genomic Research Agencies

6. Biochips Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Biochips Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Biochips PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Biochips Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Biochips Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Biochips Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Biochips Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Biochips Market Segmentation

  • 9.1. Global Biochips Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Deoxyribonucleic Acid (DNA) Chips, Protein Chips, Lab-On-Chip, Tissue Arrays, Cell Arrays
  • 9.2. Global Biochips Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microarrays, Microfluidics
  • 9.3. Global Biochips Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Drug Discovery And Development, Agriculture, Genomics, Disease Diagnostics, Proteomics, Other Applications
  • 9.4. Global Biochips Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biotechnology And Pharmaceutical Companies, Academic And Research Institutes, Hospitals And Diagnostic Centers, Other End-Users
  • 9.5. Global Biochips Market, Sub-Segmentation Of Deoxyribonucleic Acid (DNA) Chips, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gene Expression Chips, SNP (Single Nucleotide Polymorphism) Chips, DNA Microarrays
  • 9.6. Global Biochips Market, Sub-Segmentation Of Protein Chips, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Antibody Arrays, Protein Microarrays, Peptide Arrays
  • 9.7. Global Biochips Market, Sub-Segmentation Of Lab-On-Chip, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microfluidic Devices, Biosensors
  • 9.8. Global Biochips Market, Sub-Segmentation Of Tissue Arrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tumor Tissue Arrays, Normal Tissue Arrays
  • 9.9. Global Biochips Market, Sub-Segmentation Of Cell Arrays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cell-Based Biochips, Cell Signaling Arrays

10. Biochips Market Regional And Country Analysis

  • 10.1. Global Biochips Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Biochips Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Biochips Market

  • 11.1. Asia-Pacific Biochips Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Biochips Market

  • 12.1. China Biochips Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Biochips Market

  • 13.1. India Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Biochips Market

  • 14.1. Japan Biochips Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Biochips Market

  • 15.1. Australia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Biochips Market

  • 16.1. Indonesia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Biochips Market

  • 17.1. South Korea Biochips Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Biochips Market

  • 18.1. Taiwan Biochips Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Biochips Market

  • 19.1. South East Asia Biochips Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Biochips Market

  • 20.1. Western Europe Biochips Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Biochips Market

  • 21.1. UK Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Biochips Market

  • 22.1. Germany Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Biochips Market

  • 23.1. France Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Biochips Market

  • 24.1. Italy Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Biochips Market

  • 25.1. Spain Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Biochips Market

  • 26.1. Eastern Europe Biochips Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Biochips Market

  • 27.1. Russia Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Biochips Market

  • 28.1. North America Biochips Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Biochips Market

  • 29.1. USA Biochips Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Biochips Market

  • 30.1. Canada Biochips Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Biochips Market

  • 31.1. South America Biochips Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Biochips Market

  • 32.1. Brazil Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Biochips Market

  • 33.1. Middle East Biochips Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Biochips Market

  • 34.1. Africa Biochips Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Biochips Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Biochips Market Regulatory and Investment Landscape

36. Biochips Market Competitive Landscape And Company Profiles

  • 36.1. Biochips Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Biochips Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Biochips Market Company Profiles
    • 36.3.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Roche Diagnostics International Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Biochips Market Other Major And Innovative Companies

  • Bio-Rad Laboratories Inc., QIAGEN N.V., Tecan Group Ltd., Cepheid Inc., Randox Laboratories Ltd., Takara Bio Inc., Luminex Corporation, Fluidigm Corporation, Micronit Microtechnologies B.V., Sphere Fluidics Limited, Sengenics, Arrayit Corporation, CustomArray Inc., NanoCellect Biomedical Inc., Dolomite Microfluidics

38. Global Biochips Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Biochips Market

40. Biochips Market High Potential Countries, Segments and Strategies

  • 40.1 Biochips Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Biochips Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Biochips Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer